Evidence map›Paper›PMID 31317001›Full record

ArticleAnnals of translational medicine2019

Deep neural networks could differentiate Bethesda class III versus class IV/V/VI.

Yi Zhu, Qiang Sang, Shijun Jia, Ying Wang, Timothy Deyer

Abstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yi ZhuDepartments of Ultrasound, Sichuan Cancer Hospital & Institute, Cancer Hospital Affiliated to School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
Qiang SangCollege of Information Science & Technology, Chengdu University of Technology, Chengdu 610059, China.
Shijun JiaDepartment of Pathology, Sichuan Cancer Hospital & Institute, Cancer Hospital Affiliated to School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
Ying WangDepartment of Mathematics, University of Oklahoma, Oklahoma, OK, USA.
Timothy DeyerEast River Medical Imaging, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUltrasound (US) is the most commonly used radiologic modality to identify and characterize thyroid nodules. Many nodules subsequently undergo fine needle aspiration to further characterize the nodule and determine appropriate treatment. The fine needle aspirate is most commonly classified using the Bethesda System for Reporting Thyroid Cytology (TBSRTC). It can sometimes be difficult to differentiate Bethesda class III lesions (atypia of undetermined significance/follicular lesion of undetermined significance) from Bethesda class IV, V and VI (malignant nodules). However, differentiation is important as clinical management differs between the two groups. The purpose of this study was to introduce machine learning methods to help radiologists differentiate Bethesda class III from Bethesda class VI, V and VI lesions.

methodsThe authors collected 467 thyroid nodules with cytopathology results. US features were summarized using the 2017 ACR (American College of Radiology) Thyroid Imaging Reporting And Data System (TIRADS). Machine learning models [logistic regression, gradient boost, support vector machine (SVM), random forest and deep neural networks (DNN)] were created to classify Bethesda class III vs class IV/V/VI.

resultsDNN outperformed other machine learning classifiers and obtained the highest accuracy and specificity to classify thyroid nodules as either Bethesda III or IV/V/VI nodules using multiple US features.

conclusionsMachine learning/deep learning approaches could help differentiate Bethesda III nodules from IV/V/VI using US features which may benefit treatment decisions.

Indexed as

Deep neural networks (DNN)thyroid nodulesultrasound images (US images)

Identifiers

PMID31317001
PMCPMC6603360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.